To date, response criteria and optimal methods for assessment of outcome have not been standardized in patients with leptomeningeal metastasis (LM).

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

SOFFIETTI, Riccardo;Rudà, Roberta;
2014-01-01

Abstract

To date, response criteria and optimal methods for assessment of outcome have not been standardized in patients with leptomeningeal metastasis (LM).
2014
16
9
1176
1185
Antineoplastic Agents; Clinical Trials, Phase II as Topic; Endpoint Determination; Humans; Meningeal Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Patient Outcome Assessment
Chamberlain, Marc; Soffietti, Riccardo; Raizer, Jeffrey; Rudà, Roberta; Brandsma, Dieta; Boogerd, Willem; Taillibert, Sophie; Groves, Morris D; Le Rhun, Emilie; Junck, Larry; van den Bent, Martin; Wen, Patrick Y; Jaeckle, Kurt A
File in questo prodotto:
File Dimensione Formato  
Neuro Oncol-2014-Chamberlain-1176-85.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 135.02 kB
Formato Adobe PDF
135.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1537582
Citazioni
  • ???jsp.display-item.citation.pmc??? 46
  • Scopus 130
  • ???jsp.display-item.citation.isi??? 109
social impact